Asia: Market and legal data analysis of the cannabis sector

29th October 2024: Pakistan: On 31st October, the Special Investment Facilitation Council (SIFC) will hold a meeting of its implementation committee for the agriculture sector to discuss establishing the Cannabis Control and Regulatory Authority (CCRA). This follows the passage in September of related legislation in the parliament. The committee will address the processing of cannabis policy, approval of the CCRA’s organogram and other related matters.
21st October 2024: India: In Himachal Pradesh, a state in the north of the country, a pilot project has been launched to explore cannabis cultivation. This comes following the state assembly's expression of interest in legalising cannabis for medical and industrial purposes through the approval of a report advocating on the matter submitted by the revenue minister, Jagat Singh Negi. The project will be overseen by Palampur Agricultural University and Horticulture University Nauni in Solan. This initiative marks a significant step as more Indian states are beginning to consider the legalisation of cannabis for both medical and industrial purposes.
21st October 2024: Thailand: Surachoke Tangwiwat, secretary-general of the Food and Drug Administration (FDA), provided some details on the proposed regulation on cannabis extracts on Friday (18th October), explaining that the proposal would address the application process for production, import, export, sale and possession of cannabis products by private companies, press reports. Surachoke clarified that the proposal would allow cannabis extracts with more than 0.2% THC to be used for “specific purposes”, whereas now they may only be used by government agencies for medical and research purposes. CannIntelligence is in contact with Thai authorities, who confirmed passage of the proposal by the Cabinet on 8th October, to obtain a copy of the draft regulation.
18th October 2024: India: The Punjab and Haryana High Court was told in a hearing on the issue of wild cannabis in the states of Punjab, Haryana, and Chandigarh that officials from these areas will join forces to address widespread cannabis growth. The committee includes specialists from the horticulture and agriculture departments and will focus on controlling the illicit cultivation of cannabis across the region.
10th October 2024: Thailand: A proposal by the Ministry of Public Health that would regulate the possession, sale, import and export of cannabis extracts has been approved in principle by the Cabinet, press reports. The proposed regulation would impose stiff penalties for dealing in cannabis extracts without a licence. It is not yet clear, however, whether the proposal would regulate extracts with a maximum of 0.2% THC, which were removed from the narcotics list in 2022, or only those with more than 0.2% THC, which are Category 5 narcotics. The proposal will now be presented to the Council of State.
2nd October 2024: India: A Delhi-based startup, Awshad, has identified anxiety, insomnia, and mental endurance as major factors driving the demand for CBD in the country. The founders believe there is a significant gap in the market for mental well-being solutions in India, which CBD products could potentially fill. CBD oil and other products are legal in India, as long as they are produced from approved industrial hemp and contain less than 0.3% THC.
2nd October 2024: India: Indian member of Parliament (MP) Afzal Ansari has questioned the legality of cannabis in the country, citing its role in religious rituals, which resulted in the police filing a First Information Report (FIR) against him for allegedly inciting public mischief. His remarks sparked criticism from Hindu groups, prompting the Samajwadi Party politician to clarify that his intent was to address issues related to drug use and smuggling in his local area, rather than advocating for cannabis legalisation.
19th September 2024: Japan: The government has released guidance on THC limits for CBD products following a public consultation launched in May of this year. Despite the fact that the Ministry of Health made minor adjustments to the initially proposed limits, they remain among the strictest in the world. Yuji Masataka, one of the first specialists in medical cannabis in Japan, stated that products such as broad-spectrum or vapes might struggle to comply with the new regulations, which could lead to a shift towards isolate products or synthetic CBD.
19th September 2024: Thailand: The Ministry of Public Health has issued a draft law to regulate cannabis that will be under public comment until 30th September. Under the draft law, licences would be required to cultivate, produce, sell, import or export cannabis or its extracts, though an exception is made for dealing with cannabis roots, branches, stems, leaves, trunks or seeds. The sale and consumption of cannabis would only be allowed for three purposes: medicinal, research, or as herbal products, medicines, cosmetics or food if regulations for those products are complied with. Therefore, recreational use and sales would not be expressly prohibited, nor would cannabis be relisted as a narcotic. Cannabis extracts with more than 0.2% THC, however, would remain narcotics under the draft law.
17th September 2024: Japan: The Ministry of Health has said a law criminalising recreational cannabis use and legalising medicinal products derived from cannabis will enter into force in December. Medicines will need to undergo an approval process before becoming available to patients.
16th September 2024: Pakistan: The National Assembly has passed the amended Cannabis Control and Regulatory Authority Bill, 2024, following its approval by the Senate. Although the National Assembly had initially passed the bill last week, the Senate Standing Committee introduced changes that were later approved by the full Senate. As a result, the amended bill was sent back to the National Assembly for final approval.
13th September 2024: Pakistan: Yesterday (12th September), the Senate passed the Cannabis Control and Regulatory Authority Bill, 2024, which aims to regulate the cultivation and processing of hemp for medicinal and industrial purposes. Syed Hussain Abidi, chairman of the Pakistan Council of Scientific and Industrial Research (PCSIR), said the bill seeks to regulate cannabis cultivation and production for public health protection and to harness its economic potential for industrial and medicinal use, estimated at between $4bn and $6bn. The Cannabis Control and Regulatory Authority will be overseen by a 13-member board chaired by the defence secretary, with representatives from various sectors.

LATEST ALERTS

Cannabis and cannabinoids in Asia

UK NHS study first to test CBD and THC drugs together in treatment of epilepsy

Thailand’s newest government says it is pro-cannabis…and this time it’s for real

Epidiolex misses trial’s efficacy goal in Japan as it aims for drug authorisation

Israel: medical cannabis snapshot, September 2024

Developments and trends in the global cannabis industry, Q2 2024

Israel: medical cannabis snapshot, August 2023

Israel: medical cannabis snapshot, September 2024

Developments and trends in the global cannabis industry, Q2 2024

Israel: CBD and cannabis regulation, November 2023

Medical cannabis retail price tracker

Medical cannabis database

Thailand CBD insights dashboard, 2023

Regulatory tracker: current global regulation of CBD, October

Medical cannabis database

Regulatory tracker: current global regulation of recreational cannabis

Sign up to our newsletter

LATEST ALERTS

Cannabis and cannabinoids in Asia

Sign up to our newsletter

Start your FREE trial